ÂÜÀòÂÒÂ×

Dr. Li joined Atrin as Head of technology in 2017, with over 15 years of project management and scientific experience in drug discovery and development programs in large pharma, small biotech, and CROs. Prior to Atrin, Dr. Li served as Director of Medicinal Chemistry at WuXi AppTec, where she contributed to clients’ oncology programs, including two programs that advanced into clinical development. Prior to WuXi, Dr. Li worked at Merck Research Laboratories (previously Schering Plough Research Institute), where she had a strong track record in managing external resources, executing medicinal chemistry optimizations, and strengthening IP positions for lead compounds.

Dr. Li holds a BS in chemistry from the University of Science and Technology of China and a Ph.D. in chemistry from Dartmouth College.